Back to Search
Start Over
423P Fruquintinib plus sintilimab in refractory repair-proficient (pMMR)/microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Preliminary clinical results and biomarker analyses from a phase II study.
- Source :
-
Annals of Oncology . 2022 Supplement 7, Vol. 33, pS728-S728. 1p. - Publication Year :
- 2022
- Subjects :
- *COLORECTAL cancer
*METASTASIS
*BIOMARKERS
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 33
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 159077356
- Full Text :
- https://doi.org/10.1016/j.annonc.2022.07.561